1. Home
  2. LEE vs MXCT Comparison

LEE vs MXCT Comparison

Compare LEE & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

N/A

Current Price

$7.00

Market Cap

169.6M

ML Signal

N/A

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

N/A

Current Price

$1.16

Market Cap

155.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LEE
MXCT
Founded
1890
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.6M
155.8M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
LEE
MXCT
Price
$7.00
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $4.11
AVG Volume (30 Days)
33.2K
★ 1.6M
Earning Date
11-25-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $543,955,000.00
$33,026,000.00
Revenue This Year
$4.44
N/A
Revenue Next Year
N/A
$15.53
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.34
$0.64
52 Week High
$11.88
$1.81

Technical Indicators

Market Signals
Indicator
LEE
MXCT
Relative Strength Index (RSI) 55.24 40.00
Support Level $6.69 $1.02
Resistance Level $8.79 $1.27
Average True Range (ATR) 0.41 0.16
MACD 0.11 -0.04
Stochastic Oscillator 84.50 12.50

Price Performance

Historical Comparison
LEE
MXCT

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: